Phathom Pharmaceuticals Ownership | Who Owns Phathom Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Phathom Pharmaceuticals Ownership Summary


Phathom Pharmaceuticals is owned by 93.79% institutional investors, 4.56% insiders, and 1.65% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 17.10% of PHAT shares. Invesco OFI Global Equity is the top mutual fund, with 2.95% of its assets in Phathom Pharmaceuticals shares.

PHAT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPhathom Pharmaceuticals93.79%4.56%1.65%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryBiotech Stocks 34.84%11.71%53.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management12.47M17.10%$138.50M
Medicxi ventures management (jersey)7.46M10.24%$82.93M
Invesco4.32M5.93%$48.02M
Blackrock funding, inc. /de4.06M5.57%$45.13M
Millennium management4.02M5.52%$44.69M
Blackrock2.93M5.01%$30.14M
Carlyle group3.50M4.80%$38.85M
Vanguard group3.18M4.33%$52.71M
Nea management company1.96M2.69%$21.78M
683 capital management1.85M2.54%$20.55M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Medicxi ventures management (jersey)7.46M8.45%$82.93M
Catalys pacific1.49M7.19%$16.60M
Propel bio management841.27K5.90%$9.35M
Penn mutual asset management62.80K3.57%$697.73K
Frazier life sciences management12.47M3.56%$138.50M
Stepstone group lp422.08K2.26%$4.69M
Ghost tree capital600.00K1.94%$6.18M
Nea management company1.96M1.24%$21.78M
Birchview capital, lp195.00K1.23%$2.17M
683 capital management1.85M1.07%$20.55M

Top Buyers

HolderShares% AssetsChange
Millennium management4.02M0.02%1.94M
Macquarie management1.21M0.02%1.21M
Franklin resources994.50K0.00%994.50K
Perceptive advisors925.00K0.20%925.00K
Marshall wace, llp860.69K0.01%860.69K

Top Sellers

HolderShares% AssetsChange
Jennison associates---7.04M
Checkpoint capital---2.27M
Portolan capital management---1.70M
Orbimed advisors---1.45M
Tang capital management---1.20M

New Positions

HolderShares% AssetsChangeValue
Macquarie management1.21M0.02%1.21M$13.39M
Franklin resources994.50K0.00%994.50K$11.05M
Perceptive advisors925.00K0.20%925.00K$10.28M
Marshall wace, llp860.69K0.01%860.69K$9.56M
Ecor1 capital625.00K0.29%625.00K$6.94M

Sold Out

HolderChange
Srs capital advisors-6.00
Nelson, van denburg & campbell wealth management group-7.00
Sbi securities-23.00
Caitong asset management-28.00
Capital performance advisors llp-29.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026174-1.69%68,392,19810.38%931.32%11214.29%38-25.49%
Dec 31, 2025101-26.28%40,864,285-34.45%550.75%56-22.22%307.14%
Sep 30, 202574-37.82%29,531,937-48.16%400.66%37-40.32%18-45.45%
Jun 30, 2025124-11.43%57,375,847-9.22%791.03%63-12.50%378.82%
Mar 31, 2025142-4.05%64,025,009-3.98%880.84%73-22.34%3534.62%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Invesco OFI Global Equity2.34M2.95%367.07K
Invesco Global A2.34M2.94%-
Jennison Health Sciences Equity1.78M2.56%-
Vanguard Total Stock Mkt Idx Inv1.96M2.47%-
Vanguard US Total Market Shares ETF1.65M2.36%280.90K
Jennison SMid Cap Core Equity1.58M2.27%-
Strategic Advisers U.S. Total Stock{mg}1.48M2.16%-273.72K
Strategic Advisers Small-Mid Cap1.24M1.82%278.88K
PGIM Jennison Small Company A1.21M1.73%-373.30K
iShares Russell 2000 ETF1.08M1.35%9.07K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 03, 2025Breedlove Robert Charles Principal Accounting OfficerSell$7.08K
Sep 05, 2025Breedlove Robert Charles Principal Accounting OfficerSell$5.57K
Jul 16, 2025Breedlove Robert Charles Principal Accounting OfficerSell$14.15K
May 21, 2025Topper James N-Buy$14.61K
May 14, 2025Topper James N-Buy$20.92K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4-1
2025 Q3-2
2025 Q281
2025 Q113

PHAT Ownership FAQ


Who Owns Phathom Pharmaceuticals?

Phathom Pharmaceuticals shareholders are primarily institutional investors at 93.79%, followed by 4.56% insiders and 1.65% retail investors. The average institutional ownership in Phathom Pharmaceuticals's industry, Biotech Stocks , is 34.84%, which Phathom Pharmaceuticals exceeds.

Who owns the most shares of Phathom Pharmaceuticals?

Phathom Pharmaceuticals’s largest shareholders are Frazier life sciences management (12.47M shares, 17.10%), Medicxi ventures management (jersey) (7.46M shares, 10.24%), and Invesco (4.32M shares, 5.93%). Together, they hold 33.26% of Phathom Pharmaceuticals’s total shares outstanding.

Does Blackrock own Phathom Pharmaceuticals?

Yes, BlackRock owns 5.01% of Phathom Pharmaceuticals, totaling 2.93M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.14M$. In the last quarter, BlackRock increased its holdings by 180.99K shares, a 6.59% change.

Who is Phathom Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Medicxi ventures management (jersey) is Phathom Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.45% of its assets in 7.46M Phathom Pharmaceuticals shares, valued at 82.93M$.

Who is the top mutual fund holder of Phathom Pharmaceuticals shares?

Invesco OFI Global Equity is the top mutual fund holder of Phathom Pharmaceuticals shares, with 2.95% of its total shares outstanding invested in 2.34M Phathom Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools